324 related articles for article (PubMed ID: 33037057)
1. Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance.
Aschenbrenner D; Quaranta M; Banerjee S; Ilott N; Jansen J; Steere B; Chen YH; Ho S; Cox K; Arancibia-Cárcamo CV; Coles M; Gaffney E; Travis SP; Denson L; Kugathasan S; Schmitz J; Powrie F; Sansom SN; Uhlig HH
Gut; 2021 Jun; 70(6):1023-1036. PubMed ID: 33037057
[TBL] [Abstract][Full Text] [Related]
2. Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to Porphyromonas gingivalis.
Berker E; Kantarci A; Hasturk H; Van Dyke TE
J Periodontol; 2013 Sep; 84(9):1337-45. PubMed ID: 23173823
[TBL] [Abstract][Full Text] [Related]
3.
Glaser K; Silwedel C; Fehrholz M; Waaga-Gasser AM; Henrich B; Claus H; Speer CP
Front Cell Infect Microbiol; 2017; 7():484. PubMed ID: 29234642
[No Abstract] [Full Text] [Related]
4. The protease inhibitor cystatin C down-regulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes.
Gren ST; Janciauskiene S; Sandeep S; Jonigk D; Kvist PH; Gerwien JG; Håkansson K; Grip O
J Leukoc Biol; 2016 Oct; 100(4):811-822. PubMed ID: 27190304
[TBL] [Abstract][Full Text] [Related]
5. Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD.
Liu H; Dasgupta S; Fu Y; Bailey B; Roy C; Lightcap E; Faustin B
BMC Immunol; 2019 Nov; 20(1):42. PubMed ID: 31718550
[TBL] [Abstract][Full Text] [Related]
6. CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence.
Krasselt M; Baerwald C; Wagner U; Rossol M
Arthritis Res Ther; 2013 Oct; 15(5):R139. PubMed ID: 24286519
[TBL] [Abstract][Full Text] [Related]
7. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
[TBL] [Abstract][Full Text] [Related]
8. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13.
Levesque MC; Haynes BF
J Immunol; 1997 Dec; 159(12):6184-94. PubMed ID: 9550421
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.
Schreiber S; Heinig T; Thiele HG; Raedler A
Gastroenterology; 1995 May; 108(5):1434-44. PubMed ID: 7729636
[TBL] [Abstract][Full Text] [Related]
10. Impaired IL-10 Receptor-mediated Suppression in Monocyte From Patients With Crohn Disease.
Nunberg MY; Werner L; Kopylov U; Haberman Y; Lahad A; Weiss B; Shouval DS
J Pediatr Gastroenterol Nutr; 2018 May; 66(5):779-784. PubMed ID: 29045353
[TBL] [Abstract][Full Text] [Related]
11. Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity.
Tamandl D; Bahrami M; Wessner B; Weigel G; Ploder M; Fürst W; Roth E; Boltz-Nitulescu G; Spittler A
Shock; 2003 Sep; 20(3):224-9. PubMed ID: 12923493
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor downregulates inflammatory response in human monocytes through TrkA.
Prencipe G; Minnone G; Strippoli R; De Pasquale L; Petrini S; Caiello I; Manni L; De Benedetti F; Bracci-Laudiero L
J Immunol; 2014 Apr; 192(7):3345-54. PubMed ID: 24585880
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production. Role of a functional interleukin-2 receptor gamma-chain.
Bonder CS; Finlay-Jones JJ; Hart PH
Immunology; 1999 Apr; 96(4):529-36. PubMed ID: 10233738
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.
Kucharzik T; Lügering N; Weigelt H; Adolf M; Domschke W; Stoll R
Clin Exp Immunol; 1996 Jun; 104(3):483-90. PubMed ID: 9099934
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
16. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.
Schreiber S; Heinig T; Panzer U; Reinking R; Bouchard A; Stahl PD; Raedler A
Gastroenterology; 1995 Jan; 108(1):21-33. PubMed ID: 7806044
[TBL] [Abstract][Full Text] [Related]
17. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production.
Vaknin-Dembinsky A; Balashov K; Weiner HL
J Immunol; 2006 Jun; 176(12):7768-74. PubMed ID: 16751425
[TBL] [Abstract][Full Text] [Related]
18. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo.
Li S; Fossati G; Marchetti C; Modena D; Pozzi P; Reznikov LL; Moras ML; Azam T; Abbate A; Mascagni P; Dinarello CA
J Biol Chem; 2015 Jan; 290(4):2368-78. PubMed ID: 25451941
[TBL] [Abstract][Full Text] [Related]
20. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
